Valuation: Sino Medical Sciences Technology Inc.

Capitalization 9.31B 1.35B 1.14B 1.04B 990M 1.84B 122B 1.9B 12.05B 4.79B 58.87B 5.06B 4.95B 206B P/E ratio 2025 *
557x
P/E ratio 2026 * 171x
Enterprise value 9.31B 1.35B 1.14B 1.04B 990M 1.84B 122B 1.9B 12.05B 4.79B 58.87B 5.06B 4.95B 206B EV / Sales 2025 *
16.1x
EV / Sales 2026 * 12.5x
Free-Float
67.04%
Yield 2025 *
-
Yield 2026 * -
1 day+0.27%
1 week-1.37%
Current month-8.47%
1 month-5.99%
3 months+15.21%
6 months-11.31%
Current year+15.75%
1 week 22.19
Extreme 22.19
23.15
1 month 22.19
Extreme 22.19
26.26
Current year 19.75
Extreme 19.75
26.26
1 year 8.2
Extreme 8.2
47
3 years 5.8
Extreme 5.8
47
5 years 4.6
Extreme 4.6
47
10 years 4.6
Extreme 4.6
47
Manager TitleAgeSince
Chief Executive Officer 65 20/09/2007
Director of Finance/CFO 54 31/12/2012
Corporate Officer/Principal 40 26/04/2022
Director TitleAgeSince
Director/Board Member 74 05/06/2018
Director/Board Member 48 29/12/2020
Director/Board Member 60 18/06/2020
Change 5d. change 1-year change 3-years change Capi.($)
+0.27%-1.37%+104.69%+248.51% 1.35B
+2.02%+3.85%-4.19%+39.36% 140B
+0.94%+4.26%+28.69%+14.82% 15.12B
-1.10%-5.66%-17.66%-66.11% 6.41B
+0.72%-4.43%-26.54%+113.95% 6.13B
-0.79%-5.27%+36.85%+27.14% 2.82B
+0.60%-4.65%-4.81%-23.07% 2.01B
+4.51%-4.27%-66.39%-76.80% 1.7B
-1.27%-2.32%-9.57%-33.03% 1.72B
Average +0.67%-3.21%+4.56%+27.20% 19.7B
Weighted average by Cap. +1.69%+0.22%-1.83%+34.89%

Financials

2025 *2026 *
Net sales 577M 83.61M 70.46M 64.3M 61.38M 114M 7.58B 118M 747M 297M 3.65B 314M 307M 12.75B 744M 108M 90.85M 82.91M 79.14M 147M 9.77B 152M 963M 383M 4.71B 404M 396M 16.43B
Net income 18M 2.61M 2.2M 2.01M 1.91M 3.56M 236M 3.68M 23.3M 9.27M 114M 9.78M 9.58M 398M 54M 7.82M 6.59M 6.02M 5.74M 10.67M 709M 11.03M 69.9M 27.8M 342M 29.35M 28.74M 1.19B
Net Debt - -
Logo Sino Medical Sciences Technology Inc.
Sino Medical Sciences Technology Inc is a China-based company mainly engaged in the research, development, production and sales of high-end interventional medical devices. The Company's product pipeline covers the field of interventional therapy such as cardiovascular, cerebrovascular, and structural heart disease. The Company's main products include coronary drug stent system and balloon dilatation catheters. The Company conducts its businesses within the domestic market and overseas markets, and it has subsidiaries in Beijing, China, Hong Kong, China, the United States, Japan, the Netherlands, and France.
Employees
691
Date Price Change Volume
12/02/26 22.27 ¥ +0.27% 7,222,817
12/02/26 22.21 ¥ -0.94% 8,179,316
11/02/26 22.42 ¥ -0.22% 8,224,962
10/02/26 22.47 ¥ -1.53% 7,697,430
09/02/26 22.82 ¥ +1.38% 7,776,833
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
22.21CNY
Average target price
14.00CNY
Spread / Average Target
-36.97%

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688108 Stock